Cigna Group (OMDA) discloses 3,444,630 shares, a 5.8% holding

Rhea-AI Filing Summary

Omada Health, Inc. is reported to have 3,444,630 shares held by Cigna Ventures, LLC and attributable to The Cigna Group, representing 5.8% of the common stock as of 06/30/2025. The filing lists shared voting and dispositive power over those shares. The statement is signed by company officers on 06/23/2026.

Insights

Institutional Holdings Analyst

Major institutional holder reports a 5.8% stake in Omada Health.

The filing shows Cigna Ventures, LLC holds 3,444,630 shares with shared voting and dispositive power attributable to The Cigna Group. The ownership percentage is explicitly stated as 5.8% and tied to the 06/30/2025 reporting date.

This is a passive disclosure of beneficial ownership level; cash‑flow treatment and any planned transactions are not disclosed in the provided excerpt. Subsequent filings would be needed to show purchases, sales, or changes.

Key Figures

Shares beneficially owned: 3,444,630 shares Percent of class: 5.8% Reporting date: 06/30/2025

3 metrics

Shares beneficially owned 3,444,630 shares Amount beneficially owned by Cigna Ventures, LLC

Percent of class 5.8% Percent of common stock represented by the reported shares as of 06/30/2025

Reporting date 06/30/2025 Date tied to the ownership figures in the filing

Key Terms

Schedule 13G, beneficially owned, shared dispositive power

3 terms

Schedule 13G regulatory

"This statement is filed by the following entities and individuals"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Amount beneficially owned: 3,444,630"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power financial

"Shared Dispositive Power 3,444,630.00"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/23/2026 - 04:06 PM Accepted by SEC EDGAR 06/23/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What stake does The Cigna Group report in Omada Health (OMDA)?

The filing reports 3,444,630 shares, representing 5.8% of Omada Health's common stock. The statement attributes shared voting and dispositive power to The Cigna Group via its subsidiary, Cigna Ventures, LLC, as of 06/30/2025.

Which entity holds the shares attributed to The Cigna Group in the OMDA filing?

The filing identifies Cigna Ventures, LLC as the direct holder of the shares and notes it is a wholly owned subsidiary of The Cigna Group. The address for the reporting persons is shown as 900 Cottage Grove Rd., Bloomfield, CT.

What voting and disposition powers are reported for the 3,444,630 shares?

The report shows 0 sole voting power and 3,444,630 shared voting power; similarly, 0 sole dispositive power and 3,444,630 shared dispositive power are declared for these shares.

What date is the ownership percentage tied to in the OMDA Schedule 13G?

The ownership figures and percentage are presented with an explicit time anchor of 06/30/2025. The signature block in the excerpt shows signing on 06/23/2026, which is separate from the reported ownership date.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Omada Health, Inc.

(Name of Issuer)

Common stock, $0.001 par value per share

(Title of Class of Securities)

68170A108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 68170A108

1

Names of Reporting Persons

The Cigna Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,444,630.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,444,630.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,444,630.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP Number(s): 68170A108

1

Names of Reporting Persons

Cigna Ventures, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,444,630.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,444,630.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,444,630.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Omada Health, Inc.
(b)	Address of issuer's principal executive offices: 611 Gateway Blvd., Suite 120, South San Francisco, CA 94080
Item 2.
(a)	Name of person filing: This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): The Cigna Group Cigna Ventures, LLC
(b)	Address or principal business office or, if none, residence: The address of the principal business office for each of the Reporting Persons is 900 Cottage Grove Rd., Bloomfield, CT 06002.
(c)	Citizenship: The citizenship of each of the Reporting Persons is: Delaware.
(d)	Title of class of securities: Common stock, $0.001 par value per share
(e)	CUSIP Number(s): 68170A108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Cigna Ventures, LLC is a wholly owned subsidiary of The Cigna Group, and The Cigna Group may be deemed to have shared voting and dispositive power with respect to the shares held by Cigna Ventures. Amount beneficially owned: 3,444,630
(b)	Percent of class: 5.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 3,444,630
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 3,444,630
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Cigna Group

Signature:	/s/ Andrea Nelson
Name/Title:	Executive Vice President, General Counsel and Corporate Secretary
Date:	06/23/2026

Cigna Ventures, LLC

Signature:	/s/ Craig Cimini
Name/Title:	President
Date:	06/23/2026